Literature DB >> 11095895

Infections Associated with Health-care Personnel: Vaccine-preventable Diseases and Bloodborne Pathogens.

.   

Abstract

Health-care personnel (HCP) are at risk for infection from occupational exposure, and can transmit infectious pathogens to patients and other personnel. The risk of disease acquisition depends on factors including the virulence of the causative organism, the mode of pathogen transmission, and the immune competency of the exposed individual. This article reviews the management of occupational exposure, infection, and strategies for the prevention of transmission of selected vaccine-prevent- able diseases (varicella zoster virus, influenza, pertussis) and bloodborne pathogens (hepatitis B virus, hepatitis C virus, human immunodeficiency virus). Recommended strategies include surveillance, vaccination, infection control measures, and postexposure prophylaxis. Improved detection, management, and prevention strategies are needed to reduce the risk of trans- mission of infection to HCP.

Entities:  

Year:  2000        PMID： 11095895     DOI： 10.1007/s11908-000-0047-3

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  47 in total

1.  Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.

Authors:  S A Halperin; R Bortolussi; J M Langley; B Miller; B J Eastwood
Journal:  Pediatrics       Date:  1997-07       Impact factor: 7.124

2.  Simultaneous infection with HIV and hepatitis C virus following occupational conjunctival blood exposure.

Authors:  G Ippolito; V Puro; N Petrosillo; G De Carli; G Micheloni; E Magliano
Journal:  JAMA       Date:  1998-07-01       Impact factor: 56.272

3.  Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee.

Authors:  J S Garner
Journal:  Infect Control Hosp Epidemiol       Date:  1996-01       Impact factor: 3.254

4.  Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers.

Authors:  M D Nettleman; M Schmid
Journal:  Infect Control Hosp Epidemiol       Date:  1997-07       Impact factor: 3.254

5.  Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Authors:  F G Hayden; A D Osterhaus; J J Treanor; D M Fleming; F Y Aoki; K G Nicholson; A M Bohnen; H M Hirst; O Keene; K Wightman
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

6.  Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  R S Sperling; D E Shapiro; R W Coombs; J A Todd; S A Herman; G D McSherry; M J O'Sullivan; R B Van Dyke; E Jimenez; C Rouzioux; P M Flynn; J L Sullivan
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

7.  Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial.

Authors:  W F Carman; A G Elder; L A Wallace; K McAulay; A Walker; G D Murray; D J Stott
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

8.  Effectiveness of influenza vaccine in health care professionals: a randomized trial.

Authors:  J A Wilde; J A McMillan; J Serwint; J Butta; M A O'Riordan; M C Steinhoff
Journal:  JAMA       Date:  1999-03-10       Impact factor: 56.272

9.  A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

Authors:  D M Cardo; D H Culver; C A Ciesielski; P U Srivastava; R Marcus; D Abiteboul; J Heptonstall; G Ippolito; F Lot; P S McKibben; D M Bell
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

10.  Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group.

Authors:  J I Tokars; R Marcus; D H Culver; C A Schable; P S McKibben; C I Bandea; D M Bell
Journal:  Ann Intern Med       Date:  1993-06-15       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.